aMoon Fund
aMoon is a leading healthtech &a; life sciences venture capital firm.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed aMoon Fund Information
Geographic Data
Address: 34 Yerushalaim Rd
City: Raanana
State: tel aviv district
Zip: 4350110
Country: IL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
6,356,548Website Global Rank
970Website Monthly Traffic
Twitter Followers
Description
aMoon is a leading healthtech &a; life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2019 | Seer | Series D | 55M |
| 1/2020 | Mammoth Biosciences | Series B | 0 |
| 9/2019 | Igentify | Equity | 10.5M |
| 8/2017 | Karius | Series A | 59M |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 11/2022 | Ibex Medical Analytics | Debt Financing | 0 |
| 4/2021 | AltruBio | Series A | 63M |
| 11/2022 | Nectin Therapeutics | Series A | 25M |
| 3/2019 | Theranica | Series B | 35M |
| 8/2022 | Theranica | Series C | 0 |
| 3/2021 | Absci | Venture Round | 0 |
| 12/2019 | NanoGhosts | Venture Round | 5M |
| 11/2020 | Viracta Therapeutics | Series E | 0 |
| 2/2022 | Omada Health | Series E | 0 |
| 7/2018 | Nobio | Venture Round | 3.6M |
| 4/2022 | Eleos Health | Series A | 0 |
| 12/2019 | Vocalis Health | Venture Round | 9M |
| 7/2021 | Sentient Med | Pre Seed Round | - |
| 9/2020 | PrognomiQ | Venture Round | 0 |
| 3/2018 | Medial EarlySign | Series B | 30M |
| 10/2020 | SOPHiA GENETICS | Series F | 0 |
| 9/2018 | AtaCor Medical | Series A | 9M |
| 3/2019 | Ibex Medical Analytics | Series A | 11M |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 4/2021 | Biosplice Therapeutics | Venture Round | 0 |
| 6/2020 | CuResponse | Series A | 6M |
| 7/2020 | Seer | Series D | 55M |
| 9/2020 | MiNA Therapeutics | Series A | 29.5M |
| 2/2021 | Viracta Therapeutics | Post-IPO Equity | 65M |
| 7/2020 | Nectin Therapeutics | Venture Round | 6M |
| 3/2022 | Satellite Bio | Series A | 0 |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 2/2020 | AposHealth | Series A | 11M |
| 8/2020 | Mobilion Systems | Series B | 35M |
| 6/2019 | DayTwo | Series B | 0 |
| 3/2021 | Scipher Medicine | Series C | 82M |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 4/2011 | CartiHeal | Series C | 300k |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 4/2020 | AtaCor Medical | Series B | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 5/2021 | DayTwo | Series B | 37.4M |
| 4/2021 | Sera Prognostics | Series E | 0 |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 8/2019 | MDClone | Series B | 26M |
| 5/2019 | Ayala Pharmaceuticals | Series B | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
| 9/2022 | Lyfegen | Series A | 8M |
| 3/2021 | Ibex Medical Analytics | Series B | 0 |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 4/2022 | Eleos Health | Series A | 0 |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 3/2022 | Satellite Bio | Series A | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 2/2022 | Omada Health | Series E | 0 |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
